

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Mitochondrial diseases | D028361 | EFO_0000591 | — | — | 3 | 2 | — | 2 | 6 |
| Friedreich ataxia | D005621 | Orphanet_95 | G11.11 | — | 3 | 2 | — | 1 | 5 |
| Leigh disease | D007888 | Orphanet_506 | G31.82 | — | 3 | 2 | — | 1 | 5 |
| Melas syndrome | D017241 | EFO_0000192 | E88.41 | — | 1 | 2 | — | 1 | 3 |
| Diffuse cerebral sclerosis of schilder | D002549 | Orphanet_726 | G31.81 | — | 1 | 2 | — | — | 2 |
| Drug resistant epilepsy | D000069279 | — | — | — | 1 | 2 | — | — | 2 |
| Merrf syndrome | D017243 | Orphanet_551 | E88.42 | — | 1 | 2 | — | — | 2 |
| Seizures | D012640 | — | G40.4 | — | 1 | 1 | — | — | 1 |
| Status epilepticus | D013226 | EFO_0008526 | G41 | — | 1 | 1 | — | — | 1 |
| Nerve degeneration | D009410 | — | — | — | 1 | 1 | — | — | 1 |
| Drug common name | Vatiquinone |
| INN | vatiquinone |
| Description | Vatiquinone is a small molecule pharmaceutical. It is currently being investigated in clinical studies. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O |
| PDB | — |
| CAS-ID | 1213269-98-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1812161 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 6O85FK9I0X (ChemIDplus, GSRS) |
